Table 1 Percentage of survivors scoring highest score possible (ceiling).
| Â | PF | RP | BP | GH | EV | SF | RE | MH |
|---|---|---|---|---|---|---|---|---|
all survivors | 49.9 | 76.7 | 52.3 | 9.9 | 3.5 | 58.9 | 76.5 | 3.7 |
Cancer Diagnosis | Â | Â | Â | Â | Â | Â | Â | Â |
leukaemia | 56.3 | 82.6 | 57.0 | 12.0 | 5.0 | 63.6 | 79.9 | 4.5 |
Hodgkin's disease | 57.7 | 80.9 | 53.9 | 5.5 | 2.6 | 61.3 | 77.7 | 2.4 |
non-Hodgkin's | 56.6 | 81.3 | 55.3 | 10.4 | 5.0 | 59.4 | 75.1 | 3.3 |
CNS | 34.2 | 63.3 | 49.1 | 7.6 | 2.1 | 46.7 | 69.9 | 2.8 |
neuroblastoma | 45.9 | 77.3 | 50.1 | 9.8 | 4.2 | 58.8 | 77.3 | 4.4 |
retinoblastoma | 63.0 | 80.3 | 56.0 | 14.9 | 3.6 | 65.8 | 77.6 | 4.6 |
Wilms' tumour | 55.4 | 81.8 | 52.4 | 9.4 | 2.8 | 63.8 | 79.4 | 3.8 |
bone tumour | 18.1 | 61.9 | 27.2 | 6.7 | 2.1 | 50.1 | 74.5 | 4.1 |
soft tissue sarcoma | 51.2 | 77.4 | 49.5 | 10.9 | 3.8 | 60.1 | 75.4 | 4.4 |
other | 55.8 | 81.9 | 54.7 | 10.0 | 3.2 | 64.5 | 79.2 | 3.6 |
Sex | Â | Â | Â | Â | Â | Â | Â | Â |
Males | 53.1 | 77.5 | 56.0 | 11.0 | 5.0 | 62.4 | 77.7 | 5.1 |
Females | 42.5 | 71.3 | 45.6 | 8.1 | 1.7 | 52.3 | 70.1 | 2.1 |
Age* | Â | Â | Â | Â | Â | Â | Â | Â |
16–19 | 56.8 | 82.4 | 58.5 | 12.8 | 6.3 | 64.3 | 79.0 | 5.3 |
20–29 | 54.4 | 78.9 | 55.7 | 10.6 | 3.8 | 58.8 | 77.1 | 3.9 |
30–39 | 49.1 | 75.8 | 50.7 | 8.9 | 2.3 | 57.7 | 76.0 | 3.2 |
40–49 | 39.9 | 69.9 | 45.0 | 7.5 | 2.2 | 56.8 | 73.0 | 2.5 |
50+ | 21.6 | 63.2 | 34.7 | 6.7 | 1.9 | 53.6 | 74.8 | 2.7 |
Age at diagnosis | Â | Â | Â | Â | Â | Â | Â | Â |
0–3 | 51.4 | 76.6 | 53.5 | 12.0 | 4.2 | 60.0 | 75.5 | 4.3 |
4–7 | 50.2 | 75.8 | 53.2 | 9.5 | 3.6 | 58.6 | 74.3 | 4.2 |
8–11 | 44.2 | 72.2 | 49.4 | 7.7 | 2.6 | 53.5 | 73.0 | 2.9 |
12–16 | 41.8 | 70.8 | 46.6 | 7.1 | 2.3 | 54.9 | 71.5 | 2.4 |